Connect: Health Tech UEZ

Connect: Health Tech is a new University Enterprise Zone (UEZ). Initially funded by Research England (see announcement by Universities Minister Chris Skidmore in September 2019), it has been created to build a highly effective interdisciplinary bridge between two Cambridge research hubs — the West science and technology hub anchored at the Maxwell Centre and South biomedical hub anchored at the Milner Therapeutics Institute.

The bridge, powered by experienced Cambridge super-connectors, will bring together and integrate a community from across the University, research institutes, NHS, industry, investors, local and national Government, with a focus on med tech, digital health and therapeutics, to create opportunities that will transform the interface between medicine and technology.

To create a thriving business and enterprise community that connects our stakeholders the UEZ has developed a digital platform where users will be able to find new contacts and networks to discuss areas of common interest and catalyse interdisciplinary interactions across the physical and life sciences. Engaging with this online community will enable academics and businesses to share the challenges they face, and solutions that are being developed, so the community can jointly tackle real world problems.

Become a member of our growing interdisciplinary online community to benefit from joining the dots across the research ecosystem. Please visit connect.cam.ac.uk to find out more.  

Vision and structure

Joining the dots to turn ideas at the interface between medicine and technology into reality

 

Strategic Partners 

University of Cambridge (UEZ Lead: Prof Andy Neely, Pro-Vice Chancellor for Enterprise and Business Relations):

• Milner Therapeutics Institute*
• Maxwell Centre*
• Office for Translational Research*
• Cambridge Academy of Therapeutic Sciences*
• Cambridge Enterprise
• Judge Business School
• Office of Postdoctoral Affairs
• IdeaSpace

*) jointly tasked with leading the delivery of the UEZ

External Partners in the bid:

• Association of the British Pharmaceutical Industry
• Association of the British Healthcare Industries
• Astra Zeneca
• Babraham Research Campus
• Bradfield Centre
• Cambridge Innovation Capital
• Cambridge Network
• Cambridgeshire and Peterborough Combined Authority
• Cambridge University Health Partners
• Cartezia
• Eastern Academic Health Science Network
• Cytiva
• One Nucleus
• Start Codon